KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 103 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $244 | +24.5% | 14,026 | +0.7% | 0.00% | – |
Q2 2023 | $196 | +30.7% | 13,928 | -0.3% | 0.00% | – |
Q1 2023 | $150 | -54.3% | 13,974 | -36.1% | 0.00% | – |
Q4 2022 | $328 | -99.9% | 21,874 | -0.0% | 0.00% | – |
Q3 2022 | $281,000 | +76.7% | 21,884 | +33.5% | 0.00% | – |
Q2 2022 | $159,000 | -62.9% | 16,398 | -61.9% | 0.00% | – |
Q1 2022 | $428,000 | +6.2% | 43,094 | +25.7% | 0.00% | – |
Q4 2021 | $403,000 | +84.9% | 34,277 | +79.1% | 0.00% | – |
Q3 2021 | $218,000 | -36.3% | 19,134 | -22.0% | 0.00% | – |
Q2 2021 | $342,000 | -24.0% | 24,522 | +0.9% | 0.00% | – |
Q1 2021 | $450,000 | +4.9% | 24,300 | 0.0% | 0.00% | – |
Q4 2020 | $429,000 | +58.9% | 24,300 | +38.1% | 0.00% | – |
Q3 2020 | $270,000 | -39.7% | 17,600 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $448,000 | +112.3% | 17,600 | +29.4% | 0.00% | – |
Q1 2020 | $211,000 | +40.7% | 13,600 | 0.0% | 0.00% | – |
Q4 2019 | $150,000 | +29.3% | 13,600 | 0.0% | 0.00% | – |
Q3 2019 | $116,000 | -37.0% | 13,600 | 0.0% | 0.00% | – |
Q2 2019 | $184,000 | +166.7% | 13,600 | +257.9% | 0.00% | – |
Q1 2019 | $69,000 | -35.5% | 3,800 | 0.0% | 0.00% | – |
Q4 2018 | $107,000 | – | 3,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |